Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15Neoplasm Metastasis 7Lung Neoplasms 5Neoplasms 3Adenocarcinoma 3Recurrence 2Lymphoma, Large-Cell, Anaplastic 2Granuloma, Plasma Cell 2Colorectal Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Relapsed Pediatric Solid Tumor 1Rare Tumor 1Neurofibromatosis 2 1Lymphoma, Follicular 1Lung Adenocarcinoma Metastatic 1Glioma 1Glioblastoma 1Gallbladder Neoplasms 1Endometrial Cancer Recurrent 1Diffuse Intrinsic Pontine Glioma 1Castration-resistant Prostate Cancer 1Carcinoma, Squamous Cell 1Carcinoma, Lobular 1Breast Neoplasms 1Advanced Cancers 1

Interventions

Surveys and Questionnaires 5pazopanib 3Erlotinib Hydrochloride 3Cetuximab 3Vorinostat 2Oxaliplatin 2Bevacizumab 2Azacitidine 2temsirolimus 1satraplatin 1ixazomib 1X-Rays 1Videotape Recording 1Valproic Acid 1Trastuzumab 1Sugars 1Sorafenib 1Platinum 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Leucovorin 1Lenalidomide 1Lapatinib 1LY 2275796 1Fluorouracil 1Everolimus 1Curcumin 1Crizotinib 1Capecitabine 1Asian ginseng 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Cancers × Crizotinib × Clear all
NCT01548144 2021-09-13

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Terminated
178 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡